Αποτελέσματα Αναζήτησης
Ali Zumla: respiratory medicine and global health supremo. Whether it is in his clinical work or endeavouring to connect colleagues across continents for future pandemic preparedness, Ali Zumla is motivated by improving patient care and the health of neglected populations.
29 Ιαν 2022 · Whether it is in his clinical work or endeavouring to connect colleagues across continents for future pandemic preparedness, Ali Zumla is motivated by improving patient care and the health of neglected populations.
Katherine Floyd, Philippe Glaziou, Alimuddin Zumla, Mario Raviglione Tuberculosis is the number one cause of death from infectious disease globally and drug-resistant forms of the disease are a major risk to global health security.
30 Δεκ 2009 · Professor Alimuddin Zumla. Developing life threatening, crippling tuberculous meningitis while a junior doctor working in London did not stop Alimuddin Zumla from going on to make what colleagues judge to be a “unique, remarkable, and substantial” contribution to improving health care globally.
22 Μαΐ 2024 · Since 1994, Sir Zumla has been Professor of Infectious Diseases and International Health at University College London, one of Europe’s largest and top ranked academic institutions. He is also consultant infectious Diseases Physician at UCLHospitals NHS Trust.
1 Μαρ 2020 · In 2018, critical concentrations were revised or established for performing DST for the WHO Group A drugs that are strongly recommended in the treatment of DR-TB. These include the later-generation fluoroquinolones (levofloxacin and moxifloxacin), bedaquiline, and linezolid.
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at providing clinicians and public health staff with an updated and easy-to-consult document arising from consensus of Glob …